391 related articles for article (PubMed ID: 23318796)
1. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients.
Armand-Lefèvre L; Angebault C; Barbier F; Hamelet E; Defrance G; Ruppé E; Bronchard R; Lepeule R; Lucet JC; El Mniai A; Wolff M; Montravers P; Plésiat P; Andremont A
Antimicrob Agents Chemother; 2013 Mar; 57(3):1488-95. PubMed ID: 23318796
[TBL] [Abstract][Full Text] [Related]
2. ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and
Jacobs MR; Abdelhamed AM; Good CE; Rhoads DD; Hujer KM; Hujer AM; Domitrovic TN; Rudin SD; Richter SS; van Duin D; Kreiswirth BN; Greco C; Fouts DE; Bonomo RA
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323050
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
Lee JY; Kang CI; Ko JH; Lee WJ; Seok HR; Park GE; Cho SY; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
[TBL] [Abstract][Full Text] [Related]
4. Antibiotics with activity against intestinal anaerobes and the hazard of acquired colonization with ceftriaxone-resistant Gram-negative pathogens in ICU patients: a propensity score-based analysis.
Boutrot M; Azougagh K; Guinard J; Boulain T; Barbier F
J Antimicrob Chemother; 2019 Oct; 74(10):3095-3103. PubMed ID: 31289826
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
Kiddee A; Assawatheptawee K; Na-Udom A; Treebupachatsakul P; Wangteeraprasert A; Walsh TR; Niumsup PR
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891594
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
Karaaslan A; Soysal A; Altinkanat Gelmez G; Kepenekli Kadayifci E; Söyletir G; Bakir M
J Hosp Infect; 2016 Jan; 92(1):67-72. PubMed ID: 26601601
[TBL] [Abstract][Full Text] [Related]
7. Imipenem-resistant Gram-negative bacterial isolates carried by persons upon medical examination in Korea.
Kim SY; Shin SY; Rhee JY; Ko KS
J Microbiol; 2017 Aug; 55(8):612-618. PubMed ID: 28721477
[TBL] [Abstract][Full Text] [Related]
8. Rectal Carriage of Extended-Spectrum Beta-Lactamase and Carbapenemase Producing Gram-Negative Bacilli in Intensive Care Units in Tunisia.
Hammami S; Dahdeh C; Mamlouk K; Ferjeni S; Maamar E; Hamzaoui Z; Saidani M; Ghedira S; Houissa M; Slim A; Boutiba-Ben Boubaker I
Microb Drug Resist; 2017 Sep; 23(6):695-702. PubMed ID: 28099062
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Genotypic and Phenotypic Methods to Detect Carbapenemase Production in Gram-Negative Bacilli.
McMullen AR; Yarbrough ML; Wallace MA; Shupe A; Burnham CD
Clin Chem; 2017 Mar; 63(3):723-730. PubMed ID: 28073895
[TBL] [Abstract][Full Text] [Related]
10. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.
Nseir S; Blazejewski C; Lubret R; Wallet F; Courcol R; Durocher A
Clin Microbiol Infect; 2011 Aug; 17(8):1201-8. PubMed ID: 21054665
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors for acquired colonization and infection due to extended-spectrum beta-lactamase-producing Gram-negative bacilli: a retrospective analysis in three ICUs with low multidrug resistance rate.
Massart N; Camus C; Benezit F; Moriconi M; Fillatre P; Le Tulzo Y
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):889-895. PubMed ID: 31898797
[TBL] [Abstract][Full Text] [Related]
12. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission.
Nseir S; Grailles G; Soury-Lavergne A; Minacori F; Alves I; Durocher A
Clin Microbiol Infect; 2010 Jul; 16(7):902-8. PubMed ID: 19694760
[TBL] [Abstract][Full Text] [Related]
14. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
Mushtaq S; Vickers A; Woodford N; Livermore DM
J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
[TBL] [Abstract][Full Text] [Related]
15. High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico.
Uc-Cachón AH; Gracida-Osorno C; Luna-Chi IG; Jiménez-Guillermo JG; Molina-Salinas GM
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31540314
[No Abstract] [Full Text] [Related]
16. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic-resistant gram-negative bacterial infections in patients with cancer.
Perez F; Adachi J; Bonomo RA
Clin Infect Dis; 2014 Nov; 59 Suppl 5(Suppl 5):S335-9. PubMed ID: 25352627
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units.
Golden AR; Adam HJ; Baxter M; Walkty A; Lagacé-Wiens P; Karlowsky JA; Zhanel GG
Diagn Microbiol Infect Dis; 2020 May; 97(1):115012. PubMed ID: 32081522
[TBL] [Abstract][Full Text] [Related]
20. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
Tacconelli E; Mazzaferri F; de Smet AM; Bragantini D; Eggimann P; Huttner BD; Kuijper EJ; Lucet JC; Mutters NT; Sanguinetti M; Schwaber MJ; Souli M; Torre-Cisneros J; Price JR; Rodríguez-Baño J
Clin Microbiol Infect; 2019 Jul; 25(7):807-817. PubMed ID: 30708122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
